Temple University
Also known as: Adult Anxiety Clinic of Temple University | Dept. of Medical Oncology, Division of Medical Science, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111, USA | Edelman, Martin, M.D. | Fox Chase Cancer Center | Fox Chase Cancer Center - Cheltenham | Fox Chase Cancer Center, Dept of Nuclear Medicine, 333 Cottman Ave, Phila, PA 19111 | Fox Chase Cancer Center - Medical Oncology | Fox Chase Cancer Center, Rockledge, PA | Lewis Katz School of Medicine at Temple University | St. Luke's Hospital and Health Network, Pennsylvania | St. Luke's Hospital, Pennsylvania | St. Luke's University Health Network - Anesthesia | St Luke's University Hospital | Temple | Temple Hospital faculty member | Temple University | Temple University Health System | Temple University Hospita | Temple University Hospital | Temple University Hospital Department of OB/GYN | Temple University Hospital, Philadelphia, PA | Temple University Hospital/Temple Lung Center | Temple University Lung Center, Philadelphia, PA | Temple University Philadelphia | Temple University, Philadelphia, PA | Temple University, Philadelphia, Pennsylvania, United States, 19140 | Temple University School of Medicine, 3401 North Broad Street, Suite 745 PP, Philadelphia, PA 19140 | The Comprehensive NeuroAIDS Center (CNAC) at Temple University | The Western Pennsylvania Hospital
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1990Last known activity
Jan 31, 2026
Timeline
1880s
- Jan 1, 1888
Temple University— Founded
Drugs by trial phase (278 distinct, 301 trials)
Phase 4 (38 own, 0 via acquisition)
Phase 3 (43 own, 0 via acquisition)
Phase 2 (134 own, 0 via acquisition)
Phase 1 (50 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- alpha 1-Antitrypsin Deficiency
- Amyloidosis
- Anemia, Sickle Cell
- Angiomyolipoma
- Anxiety Disorders
- Basal Cell Carcinoma
- Bile Duct Neoplasms
- Blood Coagulation Disorders
- Borderline Personality Disorder
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Diseases
- Breast Neoplasms
- Breast Neoplasms, Male
- Carcinoma
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Medullary
- Carcinoma, Mucoepidermoid
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinoma, Verrucous
- Central Nervous System Neoplasms
- Charcot-Marie-Tooth Disease
- Chest Pain
- Cholangiocarcinoma
- Chondrosarcoma
- Cocaine-Related Disorders
- Colonic Neoplasms
- Colorectal Neoplasms
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Communicable Diseases
- Constipation
- Constriction, Pathologic
- Cystadenocarcinoma
- Cystadenocarcinoma, Serous
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Disease
- Drug-Related Side Effects and Adverse Reactions
- Emergencies
- Emphysema
- Endometrial Neoplasms
- Esophageal Diseases
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Esophageal Stenosis
- Esthesioneuroblastoma, Olfactory
- Exanthema
- Fallopian Tube Neoplasms
- Fibrosis
- Gallbladder Neoplasms
- Gastrointestinal Neoplasms
- Gastrointestinal Stromal Tumors
- Gastroparesis
- Glioblastoma
- Granuloma
- Head and Neck Neoplasms
- Hemangiosarcoma
- Hemoglobinopathies
- Hemopneumothorax
- Hemostatic Disorders
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hereditary Sensory and Motor Neuropathy
- HIV Infections
- Hodgkin Disease
- Hyperglycemia
- Idiopathic Pulmonary Fibrosis
- Infarction
- Infections
- Infertility
- Intestinal Neoplasms
- Kidney Diseases
- Kidney Neoplasms
- Laryngeal Diseases
- Laryngeal Neoplasms
- Laryngopharyngeal Reflux
- Leiomyosarcoma
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Recent trials (50)
- NCT07221942Lead sponsorPhase 2Jan 31, 2026
- NCT07221942OfficialPhase 2Jan 31, 2026
- NCT07311512CollaboratorN/AJan 23, 2026
- NCT07167446Lead sponsorEarly Phase 1Oct 14, 2025
- NCT07167446OfficialEarly Phase 1Oct 14, 2025
- NCT07043972OfficialPhase 2Jul 9, 2025
- NCT07043972Lead sponsorPhase 2Jul 9, 2025
- NCT06557330Lead sponsorPhase 2Dec 31, 2024
- NCT06557330OfficialPhase 2Dec 31, 2024
- NCT06273072CollaboratorPhase 2Dec 15, 2024
- NCT06429059CollaboratorPhase 2Jun 12, 2024
- NCT06218628OfficialPhase 1Apr 5, 2024
- NCT06218628Lead sponsorPhase 1Apr 5, 2024
- NCT06003270Overall official - principal investigatorPhase 2Sep 30, 2023
- NCT06050954Lead sponsorPhase 2Sep 30, 2023
Details
- Founded
- Philadelphia, Pennsylvania, US Jan 1, 1888
- Last known activity
- Jan 31, 2026